This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Determine the index fund with the lowest retirement cost through a concise comparison to guide a cost-aware choice.
28,256 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
Morgan Stanley’s bitcoin ETF attracted $194 million in its first month, with no net daily outflows, signaling growing...
SharpLink reveals a hefty Q1 loss tied to unrealized Ethereum markdowns, prompting a debate over Galaxy Digital's fun...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
Robinhood’s startup fund invests roughly $35 million across Stripe and ElevenLabs, signaling a strategic tilt toward ...
The Senate approved a $70 billion three-year funding package for ICE and Border Patrol, pushing the measure toward a ...
Primerica's earnings trajectory hinges on policy sales, investment product performance, and agent distribution. This ...
A bank ETF can be a reliable engine for a value-focused portfolio, capturing the cash-generating power of U.S. lender...
Choosing a short-term bond ETF can feel tricky. This guide compares IGSB and VGSH on cost, yield, risk, and portfolio...
After years of policy shifts and supply hiccups, a clearer EV roadmap is starting to emerge. This analysis explains w...
If you have $1,000? these stocks could form the core of a solid, long‑term portfolio. Learn why two consumer staples ...